Esophageal Atresia: From worry to wisdom–Parental information needs and considerations on etiology, care, and parental support

Abstract

Esophageal atresia (EA) is one of the most common congenital gastrointestinal anomalies, posing complex challenges across diagnosis, treatment, and long-term care. This narrative review addresses four key domains: etiology and diagnosis; surgical repair techniques; feeding challenges; and parental stress and support. It outlines current evidence and clinical considerations relevant to families, clinical staff, and researchers. By highlighting informational gaps and long-term concerns, the review supports improved communication, care planning, and research direction for optimizing outcomes in children with EA.

1. Introduction

Esophageal atresia (EA) is one of the most commonly encountered congenital gastrointestinal anomalies, with an incidence ranging from 1 in 3000 to 1 in 4500 live births.⁷⁷ Its diverse anatomical presentations reflect the complexity of tracheoesophageal development. The Gross classification, which categorizes EA based on the esophagus-trachea relationship and the presence of a tracheo-esophageal fistula (TEF), remains the most widely used system (Fig. 1). Treatment management is influenced by the length of the esophageal gap and the presence of associated anomalies (Table 1). Thanks to advances in surgical and perioperative care, survival rates have significantly improved, exceeding 90 % in patients with associated anomalies and approaching 100 % in isolated EA cases^{28, 47}.

Fig. 1. Anatomical classification of esophageal atresia (EA) in relation to the presence of tracheo-esophageal fistula (TEF).

The schematic illustrates the anatomical subtypes of EA as originally described by Gross,³⁸ compared to normal tracheo-esophageal anatomy. Each subtype highlights the presence and location of one or more tracheoesophageal fistula(s) and the relative length of the atretic gap. Type C, which features a proximal esophageal pouch and a distal TEF, is the most common subtype. Short-gap EA—typically Types C and D—is more commonly linked to VACTERL association. In contrast, long-gap EA—most observed in Types A and B—is more likely to occur as an isolated anomaly or in association with Trisomy 21 (see Table 1). A fifth variant, formerly designated as Type E and referred to as isolated TEF without EA, is no longer included in the standard classification system.

Table 1.

Characterization of Esophageal Atresia Based on the Gap Length.

Esophageal Gap*	Short-gap EA < 3 cm	Long-gap EA ≥ 3 cm
*Note that the gap in cm represents a historical concept. The surgical type is determined both by the distance and the ability (or inability) to perform a primary repair as a single surgical intervention.
Surgical Approach	Direct Anastomosis	Foker process33 Staged thoracotomy with tension induced esophageal growth before anastomosis
Co-Existing Findings	More commonly associated with VACTERL35	• Likely to be an isolated defect97, 103 • Associated with Down Syndrome9
Perioperative Allostatic Load	• Impact of co-existing anomalies • Impact of prematurity – if present	• Impact of chromosomal abnormalities – if present Foker Related • Prolonged postoperative mechanical ventilation • Prolonged total parenteral nutrition • Sedation weaning management • Prolonged immobility with risk for plagiocephaly43, 70
Pain/Sedation Management	< 5 days	≥ 5 days (Associated with physical dependence to drugs of sedation50, 92
Postoperative Complications	Reviews99, 104	Increased risk of complications14, 95
		SURGICAL • Anastomosis leakage • Respiratory compromise • Sepsis RECOVERY • Strictures and dysphagia • Gastroesophageal reflux • Feeding challenges (i.e., food aversion)

The table outlines the key differences and similarities between short-gap and long-gap esophageal atresia (EA) as it relates to presentation, surgical approach, and perioperative complications. Notably, newborns receiving intensive care are susceptible to positional plagiocephaly⁴³, a condition linked to developmental delays⁷⁰. Acronym: VACTERL, Vertebral, Anorectal, Cardiac, Tracheo-Esophageal fistula, Renal, Limb abnormalities.

Nowadays, prenatal counseling is integral to surgical planning and family preparation. Indeed, parents of infants with EA often face considerable emotional and ethical challenges. The Linked European Cohort of Children with Congenital Anomalies Trial (EUROlinkCAT) underscores the emotional impact experienced by families and emphasizes the importance of timely and compassionate communication²⁰. Clear explanations, empathetic support, and reliable education are essential for reducing anxiety and empowering families⁶⁸. This review addresses key questions voiced by parents and caregivers, focusing on etiology, diagnosis, surgical approaches, and postoperative care, as well as parental stress and support. For more detailed discussions on EA, we also recommend several comprehensive recent reviews^{71, 105}.

2. Approach

This review forms part of a clinical study approved by the Institutional Review Board. Parental inquiries were synthesized into six thematic domains (Fig. 2; Spanish translation provided in the Appendix), four of which are addressed in the present installment. The list of inquiries reflects our collective clinical experience rather than formal survey data. While parental voices were beyond the scope of this review, future studies should incorporate qualitative methods, such as parent-reported experiences, to provide a richer context and humanize the clinical trajectory of children with EA. The literature review was conducted using targeted PubMed searches with keywords aligned to common parental concerns. Each section is presented in two tiers: a general overview for a lay audience and a scholarly synthesis of current evidence. This dual format aims to bridge gaps in both research and family education, thereby enhancing understanding and communication among parents, clinicians, and researchers.

Fig. 2. Summary handout for parents of infants with esophageal atresia (EA).

This informational flyer summarizes six key topics for parents and caregivers of infants diagnosed with EA. It is intended to enhance understanding, reduce anxiety, and empower families throughout both the early stages of care and long-term management. The topics include: (I) etiology and diagnosis; (II) surgical repair; (III) feeding challenges; (IV) neurodevelopmental outcomes; (V) long-term quality of life; and (VI) parental support and stress management. Detailed discussions of Sections IV and V are presented elsewhere for this two-part review. A Spanish translation of the flyer is provided in the Appendix.

3. Etiology and Diagnosis of Esophageal Atresia

3.1. What is the cause of esophageal atresia?

The cause of EA is not yet fully understood; however, evidence points to a multifactorial origin involving genetic, developmental, and environmental factors.

While EA occurs as an isolated anomaly in 38 %¹⁰³ to 53.5 % of cases⁹⁷, it often coexists with other congenital malformations, frequently as part of a recognized syndrome. For instance, 10 % of patients with EA⁹⁷ have VACTERL association, which includes Vertebral, Anorectal, Cardiac, Trachea-esophageal fistula and/or Esophageal atresia, Renal, and Limb defects. Additionally, 15–20 % of cases occur in the context of CHARGE syndrome⁶⁰, which includes Coloboma, Heart defects, Atresia choanae (also known as choanal atresia), growth Retardation, Genital abnormalities, and Ear abnormalities. Chromosomal anomalies such as trisomy 18, trisomy 21⁹, or 22q11 deletions²², also increase the risk of EA. Consequently, infants with EA routinely undergo genetic evaluation.

3.1.1. Embryological mechanisms

During fetal development, the trachea and esophagus originate from a common foregut tube. The leading hypothesis, known as the ‘compartmentalization model,’ posits that foregut separation occurs via tissue folding and remodeling²⁹. Sonic Hedgehog (Shh) signaling plays a crucial role in this process, as its absence results in EA in animal models⁶¹. Additionally, transcription factors such as Sox1, which is involved in esophageal development, and Nkx2.1, associated with tracheal development, are implicated. Knockout models of either gene lead to EA, with or without TEF^{46, 74}.

3.1.2. Genetic contributors

Feingold syndrome, caused by mutations in the NMYC gene, is the best-characterized familial form of EA, affecting ~ 40 % of individuals with the condition¹². Other genetic disorders associated with EA include BRCA-related mutations in Fanconi anemia²³, CDH1 mutations¹⁰⁸, and CHD7 overexpression in CHARGE syndrome⁴⁹. The latter is a rare autosomal dominant disorder characterized by wide clinical variability, where EA is considered a minor feature¹⁰². Additionally, mutations in FANCB have been linked to EA, although their precise role remains under investigation.

3.1.3. Gene–environment interactions

Environmental exposures may exacerbate genetic susceptibility. For example, the Glutathione S-Transferase mu 1 (GSTM1) gene encodes enzymes that detoxify environmental pollutants in amniotic fluid⁸⁷. A study found that fetuses lacking functional GSTM1 alleles have more than double the risk of EA³¹. This finding supports a multifactorial model involving both environmental and genetic influences.

3.1.4. Environmental influences

Several maternal exposures have been associated with an increased risk of EA, including smoking, alcohol consumption¹¹⁰, and contact with pesticides³⁰. A meta-analysis has also identified maternal influenza as a possible contributor⁶³. Additionally, the use of certain medications during the first trimester, such as methimazole¹⁶, exogenous estrogen, or progesterone⁸¹, may disrupt embryologic development and contribute to the formation of EA.

3.2. What is the risk of esophageal atresia in future pregnancies?

The risk of EA in future pregnancies depends on whether the anomaly occurs in isolation or as part of a genetic syndrome. Syndromic EA carries a higher recurrence risk, while isolated cases generally show a very low familial recurrence rate.

EA has been described in >70 genetic syndromes (Table 1 in¹¹), and recurrence depends on the inheritance pattern and likelihood of EA manifesting within the syndrome. For instance, CHARGE syndrome follows an autosomal dominant pattern, with an affected parent having a 50 % chance of passing on the condition, though only 10–17 % of affected individuals develop EA^{49, 59}. Fanconi anemia, by contrast, is autosomal recessive, carrying a 25 % recurrence risk if both parents are carriers, but EA occurs in only about 14 % of cases²³. For families affected by these conditions, genetic counseling is strongly recommended to clarify recurrence risks and guide reproductive decisions.

In isolated EA, the recurrence risk is much lower and not precisely defined. It is thought to result from sporadic mutations, possibly influenced by environmental exposures, rather than inherited genetic traits¹¹. Sibling recurrence is estimated at only 1–3 %¹⁵, with some studies reporting no affected siblings, but occasional cases among distant relatives. Higher rates in monozygotic compared to dizygotic twins⁹⁰ further suggest a genetic contribution that remains incompletely understood.

3.3. How is esophageal atresia diagnosed?

In some cases, EA may first be suspected during pregnancy if a routine fetal ultrasound reveals polyhydramnios (excessive amniotic fluid) or an absent fetal stomach bubble, both of which may indicate impaired fetal swallowing. After birth, clinical suspicion is heightened when a newborn exhibits the classic “triad of presentation”: (1) frothy saliva or ‘bubbles’, due to ineffective swallowing; (2) vomiting, as food and liquid cannot pass through the atretic esophagus; and (3) coughing or choking during feeding, often accompanied by cyanosis—a bluish discoloration of the lips and skin. One of the most reliable early diagnostic procedures is the attempted passage of a nasogastric tube (NGT). Inability to pass the tube beyond 10–12 cm from the gum line suggests a blind-ending esophagus. A chest radiograph can then confirm the diagnosis by showing the NGT coiled in the upper esophageal pouch and either a small or absent stomach bubble. The presence of gastric gas suggests a concurrent TEF, as the fistula allows air passage into the stomach.

Definitive diagnosis relies on a combination of prenatal imaging, postnatal clinical findings, and radiographic confirmation, especially since diagnosis can be delayed in atypical or milder cases, where symptoms resemble gastroesophageal reflux disease (GERD) or oropharyngeal dysphagia.

3.3.1. Prenatal diagnosis

During the second trimester, routine fetal ultrasonography may reveal features suggestive of EA, such as a small or absent stomach bubble and polyhydramnios. In the third trimester, a more specific ultrasonographic finding—known as the ‘pouch sign’—may be observed when the fetus attempts to swallow⁵¹. Detection can be complicated by the presence of a TEF^{83, 85}, in which case fetal magnetic resonance imaging (MRI) can be employed. Additionally, amniotic fluid enzyme analysis has demonstrated high diagnostic accuracy for EA and is not affected by the presence of a TEF^{18, 105}. Despite these benefits, both fetal MRI and enzyme assays are used selectively. Fetal MRI is less widely available and may not be feasible in all clinical settings, while enzyme analysis requires amniocentesis, which carries a small but measurable risk of complications.

3.3.2. Postnatal diagnosis

Because prenatal detection remains limited, most cases of EA are diagnosed after birth. Once the triad of symptoms is recognized, a NGT placement and chest x-ray are employed as described above. Following confirmation of EA, a comprehensive evaluation is conducted to identify associated anomalies, which occur in more than 50 % of cases. Standard postnatal screening includes cardiac assessment using electrocardiography and echocardiography to identify congenital heart defects. Spinal and thoracic imaging are performed to detect vertebral abnormalities or a tethered cord, and abdominal and pelvic ultrasonography are used to evaluate renal and anorectal malformations⁹⁴. Our recent institutional analysis confirms that all infants with EA routinely undergo spinal imaging to screen for anal atresia and tethered spinal cord⁷².

3.3.3. Future directions in diagnostics

Despite improvements in imaging and prenatal surveillance, EA remains difficult to diagnose in utero, particularly in mild cases or when coexisting with other conditions like GERD. Diagnostic practices also vary among institutions. The European Paediatric Surgeons’ Association Esophageal Atresia Registry (EUPSA-EAR) has highlighted substantial inter- and intra-institutional variation in diagnostic protocols and practices⁷⁸. The development of standardized prenatal diagnostic pathways could improve early recognition, enable better coordination of care, and facilitate timely referral to specialized surgical centers³. Early diagnosis improves surgical outcomes and allows families to receive anticipatory counseling, psychological support, and comprehensive care planning before delivery.

3.4. What are the implications of VACTERL association?

VACTERL association is defined as a non-random grouping of anomalies that includes Vertebral defects, Anal atresia, Cardiac defects, Tracheo-Esophageal fistula, Renal abnormalities, and/or Limb abnormalities. A diagnosis requires the presence of at least three of these features. The presentation of VACTERL association is highly variable, necessitating individualized management strategies. Advances in surgical techniques and multidisciplinary care have greatly improved survival rates, and most children achieve typical developmental outcomes⁵⁴.

Managing VACTERL association is challenging due to its heterogeneity and the lack of standardized diagnostic criteria⁹³. Infants undergo comprehensive evaluations to identify all malformations, with an initial focus on life-threatening anomalies such as critical cardiac defects or TEF. Once stabilized, the focus shifts to anomalies with long-term implications, such as vertebral malformations. While the presence of VACTERL features alone does not fully predict outcomes, they are associated with increased mortality in EA/TEF and long-term challenges, including neurodevelopmental delays^54,86,100. Ongoing multidisciplinary follow-up is strongly recommended to optimize long-term outcomes, especially in instances of short-gap EA, where VACTERL features are more prevalent (see Table 1).

3.5. Is there a higher risk of prematurity for infants with esophageal atresia?

Premature birth, defined as delivery before 37 weeks of pregnancy, is common among infants with congenital anomalies, including EA.

Population-based analyses have shown one of the strongest associations between EA and prematurity⁷⁵, with preterm rates of up to 37 % in large multicenter cohorts⁹⁸. Institutional reviews report even higher rates, likely reflecting bias to tertiary centers²⁸. The mechanisms underlying this association are multifactorial. Maternal factors such as smoking, malnutrition, psychosocial stress, and multiple gestations are well-established risks^{37, 89}. In EA, polyhydramnios is particularly relevant, as uterine overdistension and inflammatory activation have been implicated in triggering preterm labor^{1, 67}.

4. Surgical Repair and Critical Care

4.1. How to plan for esophageal atresia repair?

Optimal care for infants with EA requires a multidisciplinary team at a specialized center. Families are encouraged to seek centers of excellence with comprehensive expertise in EA management.

The Esophageal and Airway Treatment

Program at Boston Children’s Hospital, founded in part by Dr. R.W. Jennings, was the first national center dedicated to EA and serves as a global leader in complex esophageal reconstruction. Similar programs have since emerged in the U.S. (viz., Children’s Hospital of Philadelphia; Johns Hopkins All Children’s Hospital) and abroad. International families may consult The EAT Federation (Esophageal Atresia Global Support Groups) for guidance in identifying experienced teams.²⁷

It is important to note that disparities in access to specialized care persist both nationally and globally. Addressing these inequities through institutional and international collaborations, capacity-building initiatives (e.g., workforce training, revising policies, continuous quality improvement), and sustained investments will be essential to optimize outcomes for all children with EA. While most available evidence is derived from high-resource settings, diagnostic and follow-up care disparities are particularly pronounced in low-resource environments. Future studies must account for these global inequities to ensure that surveillance guidelines are evidence-based, equitable, and broadly applicable. By prioritizing equity, health care organizations can create stronger networks and foster safer patient support environments.

4.2. How is esophageal atresia repaired?

All infants with EA require surgery to restore esophageal continuity. The surgical approach depends on the EA type (Fig. 1) and the esophageal gap length. Table 1 summarizes key differences between short- and long-gap EA management.

Short-gap EA is typically managed with primary anastomosis, directly connecting the esophageal segments shortly after birth. Long-gap EA typically requires staged interventions. The Foker process, pioneered by Dr. John Foker³³, promotes esophageal growth by applying traction sutures over 1–3 weeks before joining the segments, often involving multiple thoracotomies or thoracoscopic procedures⁶. A comprehensive review of its evolution and outcomes is available elsewhere⁴⁷. Postoperative care includes monitoring healing, assessing esophageal function, and detecting complications such as strictures or GERD. Many long-gap EA patients require further procedures within the first year⁴⁴. Subsequently, oral feeding is introduced only after confirmed esophageal integrity and function.

4.3. How do early and late complications after esophageal atresia repair impact follow-up visits?

Although surgical repair restores esophageal continuity, infants with EA remain at risk for early and late complications, necessitating close follow-up to optimize outcomes. The frequency and duration of these visits depend on the type of repair, presence of comorbidities, and postoperative course. Infants with short-gap EA typically have follow-up appointments every 4–6 months during the first two years. In contrast, those with long-gap EA often require more frequent assessments due to greater surgical complexity and higher complication rates. After age two, annual visits are generally recommended until age five, followed by periodic evaluations during adolescence to assess esophageal function and neurodevelopment.

Early complications, occurring within the first 18 months after surgical repair, are often serious. Anastomotic leaks occur in approximately 15 % of all EA patients¹⁹ and 18 %−35 % of cases involving long-gap EA³². These leaks may present with feeding difficulties, fever, increased drainage output, or respiratory distress. While minor leaks can be resolved with conservative therapy¹¹², major leaks often require reoperation³⁴ or endoscopic vacuum therapy⁶⁶. Anastomotic stricture is the most common complication, affecting 30–50 % of infants⁵, usually within the first year. It typically presents with dysphagia and respiratory distress³⁴, and treatment generally involves a series of esophageal dilations or possibly surgical revision⁵².

Late complications of EA repair can persist into childhood and adulthood, necessitating long-term follow-up. Gastroesophageal reflux affects 40–79 % of patients and may progress to GERD²¹, with symptoms such as regurgitation, heartburn, cough, and poor weight gain³⁴. Management includes medications or surgery, with regular monitoring recommended regardless of symptom presence⁵⁷. Swallowing difficulties impact over 50 % of adolescents and adults, primarily due to esophageal dysmotility and ineffective peristalsis³⁴. Symptoms can range from choking and food impaction to chest discomfort. Management may involve dietary modifications, swallowing therapy, neuromuscular stimulation, or gastrostomy tube (G-tube) placement.

Chronic respiratory issues, including wheezing, coughing, and recurrent infections, are common—especially during the first three years— and may persist into adulthood. Contributing factors include GERD, dysmotility, tracheobronchomalacia, and laryngeal clefts, all of which increase the risk of aspiration and long-term morbidity⁵⁶. Structural anomalies like tracheobronchomalacia are present in ~87 % of EA patients, while laryngeal clefts occur in ~20 %, both significantly contributing to recurrent complications^{53, 62}. Tracheomalacia affects ~86 % of patients, though only about 10 % require intervention²; mild cases often improve over time and are typically identified during follow-up bronchoscopy. Vocal cord dysfunction, including paresis or paralysis, occurs in 3 %−17 % of EA patients^{57, 79}, raising aspiration and chronic infection risk^{8, 42}, particularly in long-gap EA due to complex surgical techniques and prolonged postoperative intubation⁷⁹. Additionally, a higher risk of asthma and allergies has been reported in this population⁹¹.

Recognizing the chronic and lifelong implications of EA, we emphasize the need for a structured transition to adult-oriented care. This process requires coordinated involvement of gastroenterology, pulmonology, and psychological services to ensure continuity of surveillance and management across the lifespan (see also Section 6.3 below). Neurodevelopmental outcomes and long-term quality of life following EA repair are discussed at length in a separate review.

5. Feeding

5.1. What are the nutritional and growth challenges after esophageal atresia repair?

EA presents unique nutritional challenges, yet studies indicate that affected infants can achieve growth trajectories comparable to healthy peers. Multidisciplinary care teams—including surgeons, pediatricians, and nutritionists—develop individualized nutritional plans to optimize growth. Enteral feeding via G-tube is often employed to bypass the esophagus, and in some cases, total parenteral nutrition (TPN) may be administered intravenously until definitive repair is completed.

Infants with congenital cardiac anomalies have a two-fold increased risk of being small for gestational age³⁶ and often exhibit slower post-natal weight gain¹³. Similarly, gastrointestinal anomalies, including EA, increase the risk of low birth weight (<10th percentile)⁸². When surgical repair of EA is delayed due to prematurity, respiratory instability, or comorbidities, nutritional management is guided by pediatric dietitians. Pre-operative nutritional support through TPN or enteral feeding ensures growth^{39, 40}, and G-tube placement may be necessary in long-gap EA, depending on the clinical context^{4, 84}. Reference growth curves are available for parental guidance (Table 1 in¹¹¹).

Despite these challenges, the current standard of nutritional and feeding management generally supports appropriate somatic growth. Specifically, infants undergoing primary repair for short-gap EA typically attain age-appropriate weight by three years of age, despite initial post-discharge deficits related to limited oral intake, increased metabolic demand, and postoperative GERD³⁹. Infants with long-gap EA also gain adequate weight over time. However, absolute weight may remain below population norms, and patients often require prolonged hospitalization and extended nutritional support, including TPN and G-tube feeding⁴⁰. A recent pilot study reported that infants with long-gap EA following the Foker process reached weight milestones comparable to healthy term-born infants by one year of age⁷, underscoring the importance of proactive, individualized nutritional support during infancy.

5.2. How is the transition to oral feeding managed after esophageal atresia repair?

Following EA repair, the primary goal is a gradual transition to oral feeding, tailored to each infant’s clinical status. Nutritional support may involve TPN, enteral feeds, or both, depending on institutional protocols. Some infants begin oral feeds directly, while others start with small-volume tube feeds, which are gradually increased as tolerated. Once enteral feedings are tolerated, oral trials with formula or expressed breast milk are introduced and advanced until full oral intake is achieved, allowing removal of the NGT or G-tube support.

After repair, infants typically receive a combination of TPN and enteral feeds, avoiding trans-anastomotic tubes due to the risk of stricture formation⁵⁸. Long-gap EA patients often begin with TPN until there is sufficient esophageal length for safe repair. An esophagogram is generally performed around postoperative days 5–7 to assess anastomotic integrity and determine readiness for enteral feeding⁴⁰. Feeding readiness is frequently assessed by a speech-language pathologist, who helps guide the timing of oral trials⁴⁰.

Tube weaning is most successful in a multidisciplinary setting emphasizing hunger as a motivator²⁶. Approaches include gradual reduction of tube feeds while introducing oral foods, with continued support to ensure safe progression⁴¹. Invasive inpatient programs, such as the Graz model^{24, 69}, accelerate tube weaning over 2–3 weeks, pairing supervised feed reduction with sensory and play-based oral exposure. In cohorts following this approach, 95 % of EA patients achieved full oral intake regardless of gap length⁶⁹. Most short-gap EA patients transition to full oral intake shortly after discharge, though some require supplemental tube feeds at home³⁹. In contrast, long-gap EA patients may require tube support for 1–2 years, but by age three, nearly all achieve exclusive oral intake^{39, 40}.

5.3. What is the likelihood of experiencing feeding challenges after esophageal atresia repair?

Feeding difficulties are common after EA repair, often manifesting as food refusal, gagging, vomiting, or turning away during meals. These challenges frequently stem from prolonged tube feeding, dysphagia, or GERD. Nevertheless, most children successfully achieve key feeding milestones over time⁵⁵.

Reported rates of feeding difficulty following EA repair vary widely due to differences in definitions and study designs¹⁰⁶. Current estimates indicate that 28 %–79 % of children are affected^{64, 73}. These challenges are more pronounced in children with associated anomalies compared to those with isolated EA. Dysphagia impacts up to 50 % of children with EA¹⁷, making feeding uncomfortable and discouraging oral intake⁶⁴. Additionally, GERD contributes to discomfort, often resulting in food aversion and avoidance behaviors⁶⁴.

Targeted early intervention can shorten the course of feeding difficulties, and multidisciplinary teams effectively address complex cases⁸⁸. Hunt et al.⁴⁴ described the use of ‘sham feeds,’ where infants suck on a breast or bottle while nutrition is provided via tube, reinforcing oral-motor feeding skills and linking sucking to satiety. Education about feeding problems equips caregivers to foster progress⁴⁸, while peer networks and parent groups provide emotional and practical support¹⁰⁶. Positive role modeling, gentle encouragement, and consistent reassurance further help children adapt to feeding challenges⁷⁶.

6. Parental Stress Awareness and Support

6.1. Is parental stress a common response to the diagnosis of EA?

Parental stress is a common and well-documented response to the diagnosis and management of EA. Families frequently experience anxiety, emotional strain, and psychosocial burden, especially in the period immediately after early diagnosis and surgical repair. Stress is intensified by long neonatal intensive care admissions, uncertainty about prognosis, and the possibility of long-term complications. Younger parental age, financial pressures, and limited social support further increase vulnerability to parental mental health challenges¹⁰⁷.

The diagnosis, usually made at birth, often comes unexpectedly and triggers feelings of shock, confusion, and anger.^65,101 These initial reactions can evolve into more persistent psychological difficulties, including anxiety, depression, and symptoms of post-traumatic stress disorder^{107, 109}. Subsequently, feeding and mealtime challenges are particularly distressing and strongly linked to parental anxiety and depression^{96, 106}. Over time, stress levels generally decline as the child stabilizes and symptoms improve¹⁰⁹. Given these risks, healthcare teams should identify vulnerable families early and provide access to psychosocial support. Families should also feel encouraged to openly share the difficulties they face, with the reassurance that these challenges are common and understood by providers as part of the broader experience of raising a child with EA. Referral to social workers, mental health professionals, and parent networks can help reduce the emotional burden and improve family well-being.

6.2. Which resources can help parents manage the challenges after esophageal atresia repair?

A variety of resources can help parents manage the challenges of caring for a child with EA. Multidisciplinary medical care is essential, with pediatricians, surgeons, speech and language therapists, occupational therapists, and dietitians working together to address the child’s complex and evolving needs⁸⁰.

Early intervention programs that target feeding difficulties, developmental delays, or respiratory complications further improve outcomes while easing caregiver strain⁸⁰. Communication within these teams is equally important: collaborative and supportive interactions reduce parental stress, whereas poor communication can heighten anxiety and frustration^{20, 68}. Beyond the healthcare system, peer and community-based support also play a critical role. Parent support groups foster connection, reduce isolation, and offer practical advice not always available in clinical care. A recent global survey confirmed that support networks dedicated to EA significantly improved the emotional well-being of both caregivers and patients²⁰. Online platforms expand these opportunities by offering information and peer-to-peer exchange. Resources such as the EA/TEF Family Support Connection (EA-TEF Child and Family Support Connection)²⁵ and The EAT Federation (Esophageal Atresia Global Support Groups)²⁷ offer reliable guidance, while social media groups like Bridging the Gap of EA/TEF (on Facebook) allow families to share experiences and seek advice. Although these forums are valuable for building community, families should confirm any medical information with qualified professionals to avoid misinformation.

6.3. How can families best prepare for long-term follow-up at their home institution?

When transitioning from a specialized center to local care, families must establish continuity with clinicians who are familiar with EA and its long-term implications. This process is most successful when the tertiary team helps identify local providers and specialists equipped to manage ongoing needs.

Some complications, including feeding difficulties, GERD, and recurrent respiratory infections, often improve with age⁸⁰. Others, such as esophageal dysmotility, often persist and require continued monitoring and intervention²¹. For this reason, long-term follow-up is essential and should be coordinated by a multidisciplinary team experienced in the sequelae of EA. Regular assessments throughout childhood and adolescence allow clinicians to identify emerging complications, guide timely interventions, and support healthy growth and development^{10, 45}. A structured follow-up schedule has been proposed to standardize this process (Fig. 1 of⁴⁵).

Continuity of care into adulthood is equally critical. Adolescents with EA are at risk of being lost to follow-up¹⁰. Current guidelines from The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition recommend routine upper endoscopy beginning at age 18, followed by surveillance every 5–10 years or sooner if symptoms are present⁵⁷. As research continues to clarify the long-term risks associated with EA, life-long, individualized care plans will be necessary to safeguard health and quality of life well beyond childhood. Ultimately, helping families prepare for long-term follow-up not only ensures medical safety but also strengthens their confidence, reduces stress, and empowers them to navigate the lifelong journey of raising a child with esophageal atresia.

7. Conclusion

Children with EA face chronic, multisystem challenges extending well beyond initial surgical repair. While advances in surgical techniques and multidisciplinary care have improved survival, critical gaps remain, including the paucity of longitudinal data on transition into adulthood, the limited incorporation of parent-reported outcomes in clinical studies, and the underexplored influence of disparities in access to specialized care.

Continued research and multidisciplinary collaboration are essential to optimize long-term outcomes and improve the quality of care for this unique population. Future research priorities, to name a few, should include (1) the establishment of multi-institutional registries with standardized data curation, (2) prospective evaluation of surveillance strategies, and (3) integration of qualitative methods to capture parental perspectives. Beyond surgical outcomes, greater attention is needed on neurodevelopmental trajectories, psychosocial support, and the role of social determinants of health in shaping long-term outcomes.

From a clinical standpoint, actionable strategies include implementing standardized sedation-weaning and nutrition strategies, surveillance protocols, and proactively integrating parental counseling and psychosocial services, as well as developing structured transition-to-adult-care pathways. By bridging these gaps and aligning research with family-centered priorities, the field can advance toward more coordinated and equitable management of EA across the lifespan. Finally, this review aligns with the growing movement towards family-centered care in pediatrics, emphasizing personalized, clear, and compassionate communication. By addressing informational gaps that leave parents overwhelmed, we hope this resource supports families navigating life with an infant diagnosed with EA.

Supplementary Material

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.gpeds.2025.100299.

ABBREVIATIONS

EA

esophageal atresia

G-tube

gastrostomy tube

GERD

gastroesophageal reflux disease

GSTM1

Glutathione S-Transferase mu 1 gene

MRI

magnetic resonance imaging

Shh

Sonic Hedgehog gene

NGT

nasogastric tube

TEF

tracheo-esophageal fistula

TPN

total parenteral nutrition

ACRONYMS

CHARGE

Coloboma, Heart defects, Atresia choanae (also known as choanal atresia), Retardation of growth and/or development, Genital and Ear abnormalities

VACTERL

Vertebral, Anorectal, Cardiac, Trachea-esophageal fistula and/or Esophageal atresia, Renal, and Limb defects/malformations